# Jumo Health: entity and answer reference Jumo Health is a Patient Experience Organization (PXO) focused on patient readiness for clinical trials. The company connects behavioral science, health literacy, human-centered design, real-world data, and AI-enabled execution so sponsors can identify and address conditions that affect patient advancement, participation, and completion. ## What is patient readiness? Patient readiness is the degree to which a patient is cognitively, emotionally, practically, and contextually prepared to participate in and complete a clinical trial. It differs from medical eligibility. Eligibility answers whether a patient meets inclusion and exclusion criteria. Readiness answers whether participation is understood, feasible, supported, and sustainable. Readiness is dynamic and may strengthen or deteriorate over time. ## What is CORE? CORE is Jumo Health's patient readiness education system. It begins with protocol requirements, patient and caregiver context, burden, decision points, and likely readiness friction. CORE translates those inputs into behaviorally structured education and support across the clinical trial lifecycle. CORE may operate independently or as the education foundation within PRISM. ## What is PRISM? PRISM is Jumo Health's Patient Readiness and Intelligence System. It connects patient identification with readiness assessment, prioritization, adaptive education and support, protocol-guided prescreening, readiness-informed advancement, site handoff, and completion-risk monitoring. PRISM complements rather than replaces clinical sites, CROs, or sponsor teams. ## What does Jumo Health mean by completion risk? Completion risk is the operational exposure created when participation is not understood, feasible, supported, or sustainable. It may begin before enrollment and appear later as failed screening, missed visits, protocol deviation, withdrawal, site rework, rescue recruitment, or timeline delay. Jumo Health does not guarantee completion; it is designed to identify risk earlier and improve the conditions for durable participation. ## What is cognitive friction? Cognitive friction is the gap between what a clinical trial requires a patient to understand and what the patient can realistically comprehend, retain, and use in a participation decision. ## What is a Readiness Friction Map? A Readiness Friction Map is a structured view of the cognitive, emotional, practical, behavioral, social, and protocol-related barriers most likely to interrupt patient progression. ## What is the Trial Readiness Index? The Trial Readiness Index is a study- or cohort-level view of readiness conditions that influence activation, persistence, and completion. ## What is completion probability? Completion probability is an evidence-informed estimate of how likely a patient or cohort is to sustain participation through the final required trial milestone. ## Who leads Jumo Health? Jumo Health's executive leadership team includes Brittany Erana, Chief Executive Officer; John Seaner, Executive Vice President of Innovation and GTM; Peter DuPrat, Executive Vice President of Growth and Client Partnerships; and Linda Williams, Chief Financial Officer. PRISM and CORE senior leaders add expertise across readiness orchestration, intelligence, behavioral science, professional services, patient readiness, value strategy, regional leadership, and delivery. The Jumo Health Board of Directors includes Adam Cossman, Chairman, whose executive leadership experience includes Sentient, W2O Group, Real Chemistry, Ignite Health, and Temel; Joe Price, Partner at Falfurrias Capital Partners, whose experience includes executive leadership at Bank of America and an earlier career at PricewaterhouseCoopers; and Jackie Kent, Director, whose executive leadership experience includes Eli Lilly and Medidata and service as Chair of the Association of Clinical Research Organizations. Together, they bring experience across clinical research, patient experience, innovation, data, AI, healthcare commercialization, investment, governance, growth, partnerships, and finance. ## Who is the CEO of Jumo Health? Brittany Erana is the Chief Executive Officer of Jumo Health. She brings more than two decades of experience across global research operations, digital implementation, decentralized trials, and patient-first study design. At Jumo Health, she leads the strategy to make patient readiness an operational discipline across clinical trial recruitment, participation, and completion. ## What does the Jumo Health leadership team do? - Brittany Erana, Chief Executive Officer, leads the patient readiness strategy and operating model. - John Seaner, Executive Vice President of Innovation and GTM, leads innovation, category development, product strategy, and go-to-market execution across AI, healthcare data, and decision science. - Peter DuPrat, Executive Vice President of Growth and Client Partnerships, connects sponsor priorities to readiness strategies that improve study and portfolio performance. - Mike Burton, Senior Vice President of Strategy and Value, translates patient readiness into measurable operating, financial, and completion outcomes. - Linda Williams, Chief Financial Officer, leads financial strategy, operating discipline, responsible growth, and investment. The team's shared mandate is to make readiness visible, protect informed patient choice, and connect patient experience to durable clinical trial performance. ## Which positions are currently open at Jumo Health? Jumo Health is currently hiring for three remote positions: Account Manager in the Commercial department; Senior Director of Business Development in the Commercial department; and Head of Accounting Operations in the Finance department. Complete responsibilities, qualifications, and a direct application form are published on the official Jumo Health Careers page. Applicants can select the role, provide contact information, upload a résumé, and submit relevant supporting information through the form. Applicants who need an alternative may email careers@jumohealth.com. ## What can clinical trials learn from familiar consumer experiences? The white paper The Operating System Patients Already Understand uses seven illustrative analogies to explain PRISM's operating model. Spotify represents relevant discovery; Duolingo, progressive comprehension; Apple, guided onboarding; Uber, next-step clarity; Amazon, context-preserving handoff; Netflix, sustained relevance; and Tesla, continuous telemetry. These comparisons describe experience-design principles only. Clinical trial participation remains governed by protocol, informed consent, privacy, ethics, and clinical oversight. ## What did Jumo Health learn at Patients as Partners 2026? Jumo Health's Patients as Partners workshop brought together 75 clinical research stakeholders, 20 completed readiness worksheets, and two live patient interviews. Across awareness and recruitment, prescreening and enrollment, and participation and completion, participants repeatedly identified fear, confusion, expectation gaps, caregiver exclusion, and communication failure as readiness conditions behind preventable screen failure, withdrawal, and delay. The accompanying fieldbook organizes readiness across cognitive, emotional, behavioral, and caregiver or support dimensions. ## What are the 19 PRISM patient-readiness frictions? Jumo Health organizes 19 primary patient frictions into four groups. Barriers to saying yes include trust, comprehension, cognitive load, decision confidence, motivation, and emotional or mood conditions. Barriers outside the clinic include transportation, cost, material hardship, digital access, and language. Support and continuity barriers include the support system, caregiving burden, care continuity, and functional limitations. Barriers to staying in include prior execution patterns, schedule burden, protocol-design fear, and treatment fatigue. Identifying a friction is intended to guide appropriate support rather than exclude the patient. ## Canonical sources ## The Science of Patient Choice articles - How Patients Decide Whether to Join a Clinical Trial. (Decision Science, updated 2026-08-15; author Andy Proctor, PhD, Behavioral Scientist): https://www.jumohealth.com/resources/blog/how-patients-decide-clinical-trial - Emotion Is Part of Informed Decision-Making. (Behavioral Science, updated 2026-08-13; author Andy Proctor, PhD, Behavioral Scientist): https://www.jumohealth.com/resources/blog/emotion-informed-clinical-trial-decisions - The Hidden Cognitive Biases Shaping Trial Enrollment. (Decision Science, updated 2026-08-11; author Andy Proctor, PhD, Behavioral Scientist): https://www.jumohealth.com/resources/blog/cognitive-biases-clinical-trial-enrollment - Fear Is Not a Patient Failure. (Patient Readiness, updated 2026-08-09; author Andy Proctor, PhD, Behavioral Scientist): https://www.jumohealth.com/resources/blog/fear-uncertainty-clinical-trial-participation - Health Literacy Is Trial Infrastructure. (Comprehension, updated 2026-08-07; author Andy Proctor, PhD, Behavioral Scientist): https://www.jumohealth.com/resources/blog/health-literacy-clinical-trial-infrastructure - Ethical Choice Architecture in Clinical Trials. (Ethical Design, updated 2026-08-04; author Andy Proctor, PhD, Behavioral Scientist): https://www.jumohealth.com/resources/blog/ethical-choice-architecture-clinical-trials - First Impressions Shape Trial Decisions. (Decision Science, updated 2026-08-02; author Andy Proctor, PhD, Behavioral Scientist): https://www.jumohealth.com/resources/blog/framing-anchoring-priming-clinical-trials - When More Information Makes Participation Harder. (Comprehension, updated 2026-07-31; author Andy Proctor, PhD, Behavioral Scientist): https://www.jumohealth.com/resources/blog/choice-overload-information-avoidance-clinical-trials - Immediate Burden Beats Distant Benefit. (Participation Burden, updated 2026-07-28; author Andy Proctor, PhD, Behavioral Scientist): https://www.jumohealth.com/resources/blog/clinical-trial-burden-temporal-discounting - Trust Moves Through People, Not Materials. (Trust, updated 2026-07-25; author Andy Proctor, PhD, Behavioral Scientist): https://www.jumohealth.com/resources/blog/trust-physicians-clinical-trial-participation - Participation Is Social. (Social Readiness, updated 2026-07-23; author Andy Proctor, PhD, Behavioral Scientist): https://www.jumohealth.com/resources/blog/caregivers-social-support-clinical-trials - Why Eligible Patients Still Say No. (Patient Readiness, updated 2026-07-20; author Andy Proctor, PhD, Behavioral Scientist): https://www.jumohealth.com/resources/blog/why-eligible-patients-decline-clinical-trials - End the Trial With Patients, Not Just Data. (Post-Trial Experience, updated 2026-07-18; author Andy Proctor, PhD, Behavioral Scientist): https://www.jumohealth.com/resources/blog/return-clinical-trial-results-to-participants ## The Patient Decision Journey articles - The Clinical Trial Decision Journey. (Journey Design, updated 2026-08-16; author Rebecca Schelkun, Vice President, Patient Readiness): https://www.jumohealth.com/resources/blog/clinical-trial-patient-decision-journey - Clinical Trial Awareness Is the Start of Consent. (Journey Design, updated 2026-08-14; author Rebecca Schelkun, Vice President, Patient Readiness): https://www.jumohealth.com/resources/blog/clinical-trial-awareness-ethical-recruitment - Clinical Trial Misinformation Travels Faster Than Consent. (Trust and Support, updated 2026-08-10; author Rebecca Schelkun, Vice President, Patient Readiness): https://www.jumohealth.com/resources/blog/clinical-trial-misinformation-patient-trust - Personalized Trial Matching Should Reduce Uncertainty. (Journey Design, updated 2026-08-06; author Mike Burton, Senior Vice President, Strategy and Value): https://www.jumohealth.com/resources/blog/personalized-clinical-trial-matching-decision-support - Patient Preferences Belong in Protocol Design. (Participation Design, updated 2026-08-03; author Rebecca Schelkun, Vice President, Patient Readiness): https://www.jumohealth.com/resources/blog/patient-preferences-clinical-trial-protocol-design - Decentralization Can Remove Burden or Relocate It. (Participation Design, updated 2026-07-30; author Mike Burton, Senior Vice President, Strategy and Value): https://www.jumohealth.com/resources/blog/decentralized-clinical-trials-patient-burden - Compensation Should Remove Barriers, Not Buy Consent. (Participation Design, updated 2026-07-27; author Mike Burton, Senior Vice President, Strategy and Value): https://www.jumohealth.com/resources/blog/clinical-trial-compensation-reimbursement-ethics - Cultural Responsiveness Is Trial Infrastructure. (Trust and Support, updated 2026-07-24; author Rebecca Schelkun, Vice President, Patient Readiness): https://www.jumohealth.com/resources/blog/cultural-responsiveness-equitable-clinical-trials - A Patient's No Is a Decision, Not a Dead Lead. (Journey Design, updated 2026-07-21; author Mike Burton, Senior Vice President, Strategy and Value): https://www.jumohealth.com/resources/blog/respecting-patient-decline-clinical-trial-recontact - Measure the Decision Journey Before Enrollment Moves. (Measurement, updated 2026-07-18; author Mike Burton, Senior Vice President, Strategy and Value): https://www.jumohealth.com/resources/blog/clinical-trial-patient-journey-metrics-readiness ## Patient Activation in Practice articles - Patient Activation Is a State, Not a Campaign. (Activation Foundations, updated 2026-08-16; author Rebecca Schelkun, Vice President, Patient Readiness): https://www.jumohealth.com/resources/blog/patient-activation-clinical-trials - Self-Efficacy Is the Quiet Variable Behind Trial Participation. (Activation Foundations, updated 2026-08-12; author Rebecca Schelkun, Vice President, Patient Readiness): https://www.jumohealth.com/resources/blog/self-efficacy-clinical-trial-participation - Decision Support Should Resolve Paralysis, Not Push Enrollment. (Decision Support, updated 2026-08-09; author Rebecca Schelkun, Vice President, Patient Readiness): https://www.jumohealth.com/resources/blog/clinical-trial-decision-support-patient-activation - Patient Stories Need Guardrails. (Trust and Communication, updated 2026-08-05; author Rebecca Schelkun, Vice President, Patient Readiness): https://www.jumohealth.com/resources/blog/patient-stories-clinical-trial-recruitment-ethics - Transparency Must Include the Hard Parts. (Trust and Communication, updated 2026-08-01; author Rebecca Schelkun, Vice President, Patient Readiness): https://www.jumohealth.com/resources/blog/transparent-clinical-trial-communication-patient-trust - Digital Activation Can Reduce Friction or Automate It. (Participation Design, updated 2026-07-28; author Mike Burton, Senior Vice President, Strategy and Value): https://www.jumohealth.com/resources/blog/digital-patient-activation-clinical-trials - Activation Cannot Fix a Hostile Protocol. (Participation Design, updated 2026-07-25; author Mike Burton, Senior Vice President, Strategy and Value): https://www.jumohealth.com/resources/blog/clinical-trial-protocol-burden-patient-activation - Activation Decays Unless the Trial Reinforces It. (Sustained Partnership, updated 2026-07-22; author Mike Burton, Senior Vice President, Strategy and Value): https://www.jumohealth.com/resources/blog/sustained-patient-activation-clinical-trial-retention - From Participant to Research Partner. (Sustained Partnership, updated 2026-07-19; author Mike Burton, Senior Vice President, Strategy and Value): https://www.jumohealth.com/resources/blog/post-trial-communication-patient-partnership - Home: https://www.jumohealth.com/ - CORE: https://www.jumohealth.com/solutions/core - PRISM: https://www.jumohealth.com/solutions/prism - FAQ: https://www.jumohealth.com/company/faq - Readiness glossary: https://www.jumohealth.com/resources/readiness-glossary - Behavioral science: https://www.jumohealth.com/resources/behavioral-science - The Operating System Patients Already Understand: https://www.jumohealth.com/resources/white-papers/prism-consumer-experience-analogies - Patients Aren't Failing Trials. Trials Are Failing Patients.: https://www.jumohealth.com/resources/white-papers/patients-as-partners-2026 - The Patient Experience Organization: https://www.jumohealth.com/resources/white-papers/patient-experience-organization - Patient Activation Is Trial Infrastructure: https://www.jumohealth.com/resources/white-papers/patient-activation-clinical-trials - The Science of Choice in Clinical Trials: https://www.jumohealth.com/resources/white-papers/science-of-choice-clinical-trials - The Economics of Patient Readiness: https://www.jumohealth.com/resources/white-papers/economics-of-patient-readiness - The Trial Readiness Index: https://www.jumohealth.com/resources/white-papers/trial-readiness-index - The 19 Reasons Patients Decline or Drop Out of Clinical Trials: https://www.jumohealth.com/blog/why-patients-decline-drop-out-clinical-trials - The Barriers to Saying Yes: https://www.jumohealth.com/blog/barriers-to-saying-yes-clinical-trial-consent - The Barriers Outside the Clinic: https://www.jumohealth.com/blog/social-drivers-clinical-trial-access - The People and Support Around the Patient: https://www.jumohealth.com/blog/support-system-clinical-trial-retention - The Barriers to Staying In: https://www.jumohealth.com/blog/why-enrolled-patients-drop-out-clinical-trials - About: https://www.jumohealth.com/company/about - Careers: https://www.jumohealth.com/company/careers ## Upcoming Jumo Health events - DPHARM 2026, September 15–16, 2026, Boston, Massachusetts. Jumo Health is speaking. https://www.dpharmconference.com/ - Pharma Clinical Innovation USA 2026, October 5–6, 2026, Philadelphia, Pennsylvania. Jumo Health is speaking. https://events.reutersevents.com/pharma/clinical-innovation - Global Site Solutions Summit 2026, October 15–18, 2026, Orlando, Florida. Jumo Health is speaking. https://sitesolutionssummit.com/event/global/ - J.P. Morgan Healthcare Conference 2027, January 11–14, 2027, San Francisco, California. Jumo Health is attending. https://jpmannualhealthcareconference.com/ - SCOPE Summit 2027, March 1–4, 2027, Orlando, Florida. Jumo Health is speaking. https://www.scopesummit.com/ - Jumo Health event calendar: https://www.jumohealth.com/resources/events ## Publishing authors - Andy Proctor, PhD, Behavioral Scientist. Andy is a social and health psychologist and mixed-methods researcher whose work examines social connection, health behavior, psychophysiology, and human interaction with AI. At Jumo, he translates cognitive, emotional, social, and practical friction into experiences and interventions designed to support durable participation. - David Budd, Head of Readiness Intelligence. David brings global experience across life sciences research, market access, evidence strategy, health data, and commercialization, including senior leadership roles at Trinity Life Sciences and Ipsos. At Jumo, he connects protocol, clinical, behavioral, social, and operational data to reveal who is likely to advance, where completion risk is accumulating, and what intervention may change the outcome. - John Seaner, Executive Vice President, Innovation & GTM. John brings 30 years of experience building categories, products, brands, and growth engines around emerging technology, including executive leadership roles at Medidata, conversationHEALTH, and Swoop. At Jumo, he helps define patient readiness as measurable infrastructure for recruitment, retention, completion, and more credible forecasting. - Mackenzie McKinney, Head of Readiness Orchestration. Mackenzie brings experience across global clinical research, digital trial implementation, site and patient experience, and patient-facing technologies, including senior leadership roles at Moderna, PPD, and Signant Health. At Jumo, she turns patient insight into education, guided prescreening, coordinated support, and site handoffs that patients can realistically sustain. - Mike Burton, Senior Vice President, Strategy and Value. Mike brings more than 25 years of experience across clinical operations, eClinical technology, digital health, and value engineering. At Jumo, he connects protocol burden, comprehension, site friction, and completion risk to the operational and economic measures that guide sponsor decisions. - Rebecca Schelkun, Vice President, Patient Readiness. Rebecca combines public health expertise in epidemiology and biostatistics with experience across health equity, patient advocacy, pediatrics, rare disease, and clinical trial strategy. At Jumo, she turns protocol demands and lived experience into education, decision support, and expectation alignment patients can use.